SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Xenon Reports Q3 2026 Financial Results

VANCOUVER, BC and BOSTON, MA, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. NASDAQ:XENE, a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today reported financ…

XENE
SquawkNews Desk

VANCOUVER, BC and BOSTON, MA, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. NASDAQ:XENE, a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today reported financ…

Related stories

WM Technology Q3 Revenue Falls Amid Market Headwinds M impact | EQUITY | Nov 09, 2026, 10:25 PM UTC Caixa Seguridade Reports Q3 Managerial Net Profit of 1.2 Billion Reais M impact | EQUITY | Nov 09, 2026, 10:24 PM UTC Ecopetrol Prices $2 Billion Eight-Year Bond at 7.98% Ecopetrol priced the bond on Monday as it refinances a Brava bridge loan. Notes due 2034 were launched at 7.95%, with guidance around 8.00%, plus or minus 2 basis points. M impact | EQUITY | Nov 09, 2026, 10:23 PM UTC Skydance Reports Third-Quarter Revenue of $7.03B and EPS of $0.06 Skydance said third-quarter revenue increased year over year and earnings attributable to Parent swung to a profit from a loss. Pro forma revenue rose 5%, driven by higher licensin M impact | EQUITY | Nov 09, 2026, 10:22 PM UTC IA Financial Group reports third-quarter results and raises common dividend 7% M impact | EQUITY | Nov 09, 2026, 10:19 PM UTC Briscoe Forecasts Annual Net Profit of Up to NZ$55 Million Briscoe's 3Q trading update disappointed Forsyth Barr. The retailer forecast annual net profit of up to NZ$55 million, 8% below the broker's forecast; quarterly sales rose 1% while M impact | EQUITY | Nov 09, 2026, 10:17 PM UTC